Jordan R Hanrahan, DO¹, Leroy J. Seymour, MD, MSc^1*, Anna Beckius^1*, Donna Welter^1*, Mandy Kastner, MPH^1*, Valarie Ehrlich, PA-C^2*, Kristine Broge-Reynen, MS, APNP, ANP-BC^2*, Mary Rodgers, MSN, AGNP, RN^2*, Laura C. Michaelis, MD³, Lyndsey Runaas, MD^2*, Ehab L. Atallah, MD², Sameem Abedin, MD⁴, Guru Subramanian Guru Murthy, MD^5*, Ravi Kishore Narra, MD, MS², Mary Fournogerakis, BSN, RN, OCN^6*, Jessica Schmitz, BSN, RN^6*, Andrea Viitala, BSN, RN^6*, Elizabeth Larsen, BSN, RN, OCN^6*, Amber Essenmacher, PA-C^7*, Gina George, PA-C^2*, Kim Johnston, PA-C^2*, Karen Sue Carlson, MD, PhD^2,8* and Nicole Held, DO⁹

¹Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
⁴Blood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Froedtert & the Medical College of Wisconsin Froedtert Hospital, Milwaukee, WI
⁷Incyte Corporation, Milwaukee, WI
⁸Versiti Blood Research Institute, Milwaukee, WI
⁹Division of Hematology/Oncology, Medical College of Wisconsin, Wauwatosa, WI

Allyson Waller, PharmD^1*, Shelly Brown, MS, APRN-CNS, OCN, AOCNS^2*, Tracelyn Freeman, PharmD, BCOP^3*, Pooja S. Kumar, PharmD, BCOP^1* and Alice S. Mims, MD³

¹Department of Pharmacy, The Ohio State University, Columbus, OH
²Department of Professional Practice, The Ohio State University, Columbus, OH
³Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Ricardo Khalil Khalil Tannuri^1*, Beatriz Moiraghi, MD^2*, Miguel Arturo Pavlovsky^3,4, Ana Ines Varela, MD^5*, Michele Bianchini, PhD^6*, Isabel Giere, PhD^1*, Isolda I Fernandez, MD^1*, Georgina Bendek, MD^7*, Romina Mariano, MD^8*, Josefina Freitas, MD^9*, Veronica Ventriglia, MD^9*, Maria Del Rosario Custidiano, MD^10*, Ana Garcia de Labanca, MD^11*, Julio Cesar Sanchez Avalos, MD¹², Maria J Mela Osorio, MD^1*, Bianca Vasconcelos Cordoba^6*, Maria Belen Sanchez^13*, Mariana Juni, Ms^1*, Marcos Bianco, Graduate^14* and Carolina Pavlovsky^1*

¹FUNDALEU, Buenos Aires, Argentina
²Hospital Ramos Mejía, Buenos Aires, ARG
³FUNDALEU, Buenos Aires, ARG
⁴FUNDALEU, Clinical research center Buenos Aires, Buenos Aires, Argentina
⁵Hospital General De Agudos J.M. Ramos Mejia, Ciudad Autonoma De Buenos Aires, ARG
⁶Centro de Investigaciones Oncológicas CIO-FUCA, Buenos Aires, Argentina
⁷Hospital Italiano, Buenos Aires, Argentina
⁸Hospital San Martin, Parana, Argentina
⁹Hospital Posadas, Buenos Aires, Argentina
¹⁰Instituto Alexander Fleming, Buenos Aires, ARG
¹¹Hospital Italiano, Mendoza, Argentina
¹²Instituto Alexander Fleming, Buenos Aires, Argentina
¹³Centro de Investigaciones Oncológicas CIO-FUCA, Buenos Aires, BA, Argentina
¹⁴Universidad Torcuato Di Tella, Buenos Aires, Argentina

Gregory W. Roloff, MD¹, Reid Shaw, MD^2*, Timothy E. O'Connor, MD^2* and Michael W. Drazer, MD, PhD^1*

¹Section of Hematology/Oncology, The University of Chicago, Chicago, IL
²Department of Medicine, Loyola University Medical Center, Maywood, IL

Lama Sawalha, MD^1*, Ghulam Rehman Mohyuddin, MD², Aaron M Goodman³, Nico Gagelmann^4*, Amar H Kelkar, MD⁵ and Samer Al Hadidi, MD, MSc⁶

¹Hashemite University, Amman, Jordan
²Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT
³University of California San Diego Moores Cancer Center, San Diego, CA
⁴University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR

Vivek Yadala^1,2, Kelsey Marshall, DO^3*, Bhavana Vemula, MD^4* and Mina Shenouda, MD^5*

¹Hematology & Oncology, Marshall University, Huntington, WV
²Marshall University, Huntington, WV
³Internal Medicine, Marshall University, Huntington, WV
⁴Hematology-Oncology, Marshall University, Huntington, WV
⁵Marshall University at Joan C Edwards School of Medicine, Huntington, WV

Guneet Kaleka^1*, John Sharp, MD^2*, Kailyn Kim, MD^3*, Pryce Gaynor, MD^4*, Gary J. Schiller, MD⁵ and Wanxing Chai-Ho, MD⁶

¹Department of Medicine, UCLA-Olive View Medical Center, Newbury Park, CA
²Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
³Department of Medicine, UCLA-Olive View Medical Center, Sylmar, CA
⁴UCLA Department of Medicine, Division of Infectious Disease, UCLA Health, Los Angeles, CA
⁵Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA
⁶Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA

Manali I Patel^1*, Joao L. Ascensao, MD, PhD^2*, Lindsay Gurska, PhD^3*, Shelby Sullivan, PharmD^3*, Jeffrey D Carter, PhD^3* and Cherilyn Heggen, PhD^3*

¹Stanford, Palo Alto, , USA, Palo Alto, CA
²V.A Medical Center, Washington, DC
³PRIME Education, LLC, Fort Lauderdale, FL

Dianne Pulte, MD¹, Kelly J. Norsworthy, MD², Laura Fernandes^3*, Bindu Kanapuru, MD^4*, Catherine Lerro^5*, Fatima Rizvi^5*, Jonathon Vallejo, Ph.D.^6*, Kun Wang, PhD^6*, Joseph Wynne, MD, PhD^7*, Anna Barcellos^3*, Andrew J. Belli^3*, Eric Hansen^3*, Thomas Gwise, Ph.D.^6*, Paul Kluetz^5,7*, Angelo De Claro, MD^5,7, Ching-Kun Wang^3* and Donna Rivera^5*

¹Office of Oncologic Diseases, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
²Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Severna Park, MD
³COTA, Inc, New York, NY
⁴Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Vienna, VA
⁵Oncology Center of Excellence, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD
⁶Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
⁷Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Joseph R. Mikhael, MD¹, Sam DR Dooyema^2*, Shelby Sullivan, PharmD^2*, Jeffrey D Carter, PhD^2* and Cherilyn Heggen, PhD^2*

¹Translational Genomics Research Institute (TGen), City of Hope Cancer Center, Phoenix, AZ
²PRIME Education, LLC, Fort Lauderdale, FL

Kevin R Reyes, BS^1*, Chiung-Yu Huang, PhD^2*, Mimi Lo, PharmD, BCPS, BCOP^3*, Shagun Arora, MD⁴, Alfred Chung, MD⁴, Sandy W. Wong, MD⁴, Jeffrey L. Wolf, MD⁴, Thomas Martin, MD⁵, Nina Shah, MD⁶ and Rahul Banerjee, MD⁷

¹School of Medicine, University of California, San Francisco, Millbrae, CA
²Department of Statistics, University of California San Francisco, San Francisco, CA
³Department of Pharmaceutical Services, University of California San Francisco, San Francisco, CA
⁴Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
⁵UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
⁶Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
⁷Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA